KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Amgen (AMGN) EBIAT (2016 - 2025)

Historic EBIAT for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Amgen's EBIAT rose 11259.97% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 billion, marking a year-over-year increase of 8853.3%. This contributed to the annual value of $7.7 billion for FY2025, which is 8853.3% up from last year.
  • As of Q4 2025, Amgen's EBIAT stood at $1.3 billion, which was up 11259.97% from $3.2 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's EBIAT peaked at $3.2 billion during Q3 2025, and registered a low of -$113.0 million during Q1 2024.
  • Its 5-year average for EBIAT is $1.5 billion, with a median of $1.5 billion in 2022.
  • Per our database at Business Quant, Amgen's EBIAT crashed by 10397.75% in 2024 and then skyrocketed by 163097.35% in 2025.
  • Amgen's EBIAT (Quarter) stood at $1.9 billion in 2021, then fell by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then skyrocketed by 112.6% to $1.3 billion in 2025.
  • Its EBIAT stands at $1.3 billion for Q4 2025, versus $3.2 billion for Q3 2025 and $1.4 billion for Q2 2025.